Mabel Lam Tse
About Mabel Lam Tse
Mabel Lam Tse serves as the Executive Director of Scientific Communications at Travere Therapeutics, a position she has held since 2020. She has extensive experience in the pharmaceutical industry, with previous roles at Eisai, Shionogi Inc, and various healthcare institutions.
Current Role at Travere Therapeutics
Mabel Lam Tse serves as the Executive Director of Scientific Communications at Travere Therapeutics. She has held this position since 2020, contributing to the company's focus on developing innovative therapies for rare diseases. Her role involves overseeing scientific communication strategies and ensuring that complex scientific information is effectively conveyed to various stakeholders.
Previous Experience in Pharmaceutical Industry
Mabel has extensive experience in the pharmaceutical industry, having worked in various roles across multiple organizations. She was a Drug Information Manager at Eisai from 2003 to 2006 and later advanced to Senior Drug Information Manager until 2010. She also held positions at Shionogi Inc as Associate Director of Medical Information and at Travere Therapeutics in several capacities, including Director of Medical Information and Sr. Director of Scientific Communications.
Educational Background
Mabel earned her Bachelor of Science in Pharmacy (BS Pharm) from Long Island University, completing her studies from 1990 to 1995. She furthered her education by obtaining a Doctor of Pharmacy (PharmD) from Temple University between 2007 and 2009. Additionally, she holds a Master of Business Administration (MBA) from Drexel University, also achieved during the same period.
Clinical Experience in Healthcare Settings
Mabel has a background in clinical pharmacy, having worked as a Clinical Pharmacist in the Target Drug Monitoring Program at New York Presbyterian Hospital from 1995 to 1997. She also served as a Pharmacist at Mount Sinai Medical Center from 1996 to 1999 and completed a Pharmacy Practice Residency at the Department of Veterans Affairs from 1995 to 1996. These roles provided her with a solid foundation in patient care and medication management.